|
Market Closed -
London S.E.
11:35:18 2026-10-13 EDT
|
5-day change | 1st Jan Change | ||
| 1,753.00 GBX | -1.02% |
|
-0.34% | -3.92% |
| Market Cap | 70.24B 93.12B 83.1B 77.54B 132B 8,868B 133B 927B 363B 4,597B 349B 342B 14,744B | P/E 2026 * |
13.4x | P/E 2027 * | 11x |
|---|---|---|---|---|---|
| Enterprise Value | 91.41B 121B 108B 101B 172B 11,541B 174B 1,207B 473B 5,982B 455B 445B 19,188B | EV / Sales 2026 * |
2.7x | EV / Sales 2027 * | 2.49x |
| Free-Float |
92.75% | Yield 2026 * |
3.96% | Yield 2027 * | 4.27% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| GSK | Delayed | |
CBOE
| GSK | Real-time | |
|
Xetra
| GS71 | Delayed | |
|
OTC Markets
| GLAXF | Delayed | |
|
Tradegate
| GS71 | Real-time | |
|
Boerse Muenchen
| GS71 | Real-time | |
|
Deutsche Boerse AG
| GS71 | Delayed | |
|
Mexican S.E.
| GSK1 N | End-of-day quote | |
|
Börse Stuttgart
| GS71 | Delayed |
Last Transcript: GSK plc
| 1 day | -1.02% | ||
| 1 week | -0.34% | ||
| Current month | -4.31% | ||
| 1 month | -0.99% | ||
| 3 months | -10.63% | ||
| 6 months | -19.44% | ||
| Current year | -3.92% |
| 1 week | 1,735.5 |  | 1,806.5 |
| 1 month | 1,735.5 | | 1,917 |
| Current year | 1,690 | | 2,282 |
| 1 year | 1,592 | | 2,282 |
| 3 years | 1,242.5 | | 2,282 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | 52 | 2025-12-31 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 2023-04-30 |
James Ford
CMP | Compliance Officer | - | 2018-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | 52 | 2026-05-05 |
Hal Barron
BRD | Director/Board Member | 64 | 2017-12-31 |
Jonathan Symonds
CHM | Chairman | 67 | 2019-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/22/26 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 9/18/26 | Buy | Director | 768 | 0.0000% | ||
| 9/18/26 | Buy | Director | 1,734 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.02% | -0.34% | +7.88% | +15.34% | 93.75B | |
| -1.36% | +2.05% | +39.95% | +91.07% | 1,054B | |
| -5.73% | -1.71% | +30.35% | +59.03% | 636B | |
| -2.40% | +3.24% | +19.03% | +85.00% | 497B | |
| -2.39% | +1.75% | +65.11% | +37.06% | 359B | |
| -0.06% | +3.12% | +23.98% | +42.38% | 345B | |
| -0.55% | +2.42% | +13.66% | +33.97% | 273B | |
| -1.08% | +1.12% | -6.93% | +6.98% | 246B | |
| -1.13% | +2.45% | +42.29% | +44.84% | 226B | |
| -1.67% | +2.27% | +26.23% | +92.70% | 187B | |
| Average | -0.92% | +2.90% | +26.16% | +50.84% | 391.6B | |
| Weighted average by Cap. | -0.59% | +3.13% | +30.57% | +62.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.91B 44.95B 40.12B 37.43B 63.9B 4,281B 64.36B 448B 175B 2,219B 169B 165B 7,118B | 35.51B 47.08B 42.01B 39.2B 66.92B 4,483B 67.4B 469B 184B 2,324B 177B 173B 7,454B |
| Net income | 5.31B 7.04B 6.28B 5.86B 10B 670B 10.08B 70.07B 27.45B 347B 26.4B 25.84B 1,114B | 6.32B 8.37B 7.47B 6.97B 11.91B 798B 11.99B 83.39B 32.67B 413B 31.42B 30.75B 1,326B |
| Net Debt | 21.17B 28.07B 25.05B 23.37B 39.9B 2,673B 40.18B 279B 109B 1,385B 105B 103B 4,444B | 18.28B 24.23B 21.62B 20.18B 34.45B 2,308B 34.69B 241B 94.54B 1,196B 90.9B 88.98B 3,837B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-13 | GBX 1,753.00 | -1.02% | 6,613,488 |
| 26-10-12 | GBX 1,771.00 | +1.20% | 3,352,492 |
| 26-10-09 | GBX 1,750.00 | +0.84% | 6,931,381 |
| 26-10-08 | GBX 1,735.50 | -3.07% | 16,331,288 |
| 26-10-07 | GBX 1,790.50 | +1.42% | 5,172,881 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions
